Effect of the Incoportation of Copper and Zinc Nanoparticles Into Dental Adhesives
1170575
1 other identifier
interventional
35
1 country
1
Brief Summary
The hypothesis is that Addition of copper or zinc nanoparticles to a dental adhesive confers antimicrobial and enzymatic degradation-resistant properties, retaining its adhesion mechanical properties and biocompatibility. To corroborate this hypothesis two groups of a dental adhesive doped with copper or zinc nanoparticles should be develop with a respective structural characterization by SEM-EDX, AFM and FTIR. This should be followed by a test of the antimicrobial activity of adhesive and a study of the influence of adhesive nanocomposites on matrix metalloproteases levels and/or activity in vitro to determine some concentrations more relevant. These would proceed to next stage. With the selected adhesive doped concentrations should be evaluate mechanical properties of doped adhesives and assess the biocompatibility by assays in primary cultured gingival fibroblast and cells type odontoblasts. Finally, once the concentration of either Cu- or Zn-doped adhesives is known, these will be evaluated with a clinical design phase in an in vivo model to study antimicrobial properties, matrix metaloproteases levels and/or activity. We will also study biocompatibility of adhesive nanocomposites and mechanical properties to corroborate the in vitro and ex vivo properties determined. There are results using copper nanoparticle on biomaterials that corroborates some properties such as antimicrobial activity against various species and copper release. All the evidence suggests that at low concentrations of copper nanoparticles, there are no significant effects on mechanical properties but with added antibacterial properties on the adhesive
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2018
CompletedFirst Posted
Study publicly available on registry
August 17, 2018
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedAugust 17, 2018
August 1, 2018
1 year
August 6, 2018
August 14, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
To assess antibacterial ( by inhibition of UFC grow of S Mutans count) and Micro tensile bond strengh (
UFC (Colony Forming Units) of Stretococus Mutans Count (Numbers) , Microtensile bond strength (Mpa)
baseline - 1 month post restorative procedure
In vitro and ex vivo evaluation of MMPs' activity ( Units of fluorecense by inmunofloresence antibody compared with control )
To Assess Matrix Metallopeptidase 2 , 8 and 9 activity by in vitro test and ex vivo (Luminicense units compared vs controls of fluorecence) ( dentin powder obtained fron teeth donated)
baseline - 1 month post restorative procedure
Study Arms (2)
Adhesives Cu/Zn nanoparticles doped
EXPERIMENTALAdhesive dopped with Zn Oxide + Cu nanoparticles in a ( 5% / 0.2% concentration )
Adhesive control
ACTIVE COMPARATORAdhesive conventional
Interventions
Np of OZn nanoparticles mixed with dental adhesive
Dental Adhesive with commercial preparation
Eligibility Criteria
You may qualify if:
- treatment plans indicating premolar extractions for orthodontic reasons,
- presence of healthy, intact, non-carious, non-restored, and fully erupted treatment teeth,
- patients having well-controlled health conditions that allow all procedures to be performed in the research with minimal risk
You may not qualify if:
- patients who do not agree to volunteer for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eduardo Fernández G
Santiago, Santiago Metropolitan, 7500505, Chile
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Bottles with a label remarked with 2 letters A and B , same aspect
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Profesor Titular
Study Record Dates
First Submitted
August 6, 2018
First Posted
August 17, 2018
Study Start
December 1, 2018
Primary Completion
December 1, 2019
Study Completion
January 1, 2020
Last Updated
August 17, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share